Perspectives on the potential of Mangiferin as a nutraceutical: a review
ISSN: 0034-6659
Article publication date: 25 May 2022
Issue publication date: 7 February 2023
Abstract
Purpose
The aim of this study is to provide a review of the research studies that took place in the previous years regarding Mangiferin and its potential use in the treatment of various disorders such as diabetes, cardiovascular diseases, cancer and human immunodeficiency virus.
Design/methodology/Approach
Mangiferin can be easily extracted from the plant at a very low cost to treat some common as well as deadly diseases, which will be a miracle in herbal treatment. In support of this, the recent related articles were considered to understand the bioactive compound “Mangiferin” to treat lifestyle diseases. Various review articles and research papers were collected from international and national journals, and internet sources were also being used to compile the current manuscript.
Findings
Mangiferin has been shown to have the potential to mitigate many life style diseases such as diabetes, obesity, hypertension, fatty liver, atherosclerosis, dyslipidemia and diabetes-related end-organ complications such as retinopathy, neuropathy and nephropathy.
Originality/value
In this comprehensive review, this study evaluates Mangiferin and its lifestyle disease-modifying properties for nutraceuticals purposes.
Keywords
Acknowledgements
The authors are grateful for the support they received from the Department of Biotechnology, Faculty of Engineering and Technology, Manav Rachna International Institute of Research and Studies, Faridabad, Haryana, India. The authors want to thank their mentor, Dr Joseph Davis and Dr Pushpa Tomar for their patience, insightful remarks, useful knowledge and practical counsel, all of which have been extremely beneficial to them. The authors are also grateful to Manav Rachna International University’s Department of Biotechnology, Faculty of Engineering and Technology. The literature search was carried out by Deepti Jamwal and Priyanka Saini, who also wrote the text. Apart from the literature search and paper production, Dr Pushpa Tomar and Dr Arpita Ghosh oversaw and critically examined, corrected, written many portions in the manuscript and took the major role during manuscript revision. The work was read and approved by all of the authors.
Citation
Jamwal, D., Saini, P., Tomar, P.C. and Ghosh, A. (2023), "Perspectives on the potential of Mangiferin as a nutraceutical: a review", Nutrition & Food Science, Vol. 53 No. 2, pp. 249-264. https://doi.org/10.1108/NFS-01-2022-0013
Publisher
:Emerald Publishing Limited
Copyright © 2022, Emerald Publishing Limited